Vol 7: Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.Report as inadecuate



 Vol 7: Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.


Vol 7: Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 7: Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
This article is from BMC Research Notes, volume 7.AbstractBackground: Recurrent miscarriage is a major women’s health problem. Aspirin and heparin have been shown to have potentially beneficial effects on trophoblast implantation. However, few published data on this issue are available from developing countries. Methods: An open clinical trial was conducted at the Department of Obstetrics and Gynecology at Misurata Teaching Hospital in Libya from January 2009 to December 2010 to investigate the effects of treatment with low dose aspirin LDA versus treatment with low-molecular-weight-heparin LMWH in combination with LDA on patients with a history of recurrent miscarriages. A total of 150 women were enrolled in the study. Women were eligible for the study if they had a history of three or more consecutive miscarriages. Participants were randomly assigned to receive either LDA 75 mg daily alone or a combination of LDA and LMWH 75 women per treatment group. The primary outcomes were the rate of miscarriages and live births for each group. Results: Compared with the group who received LDA alone, the combination group had a significantly lower number of miscarriages 22-75 29% vs. 43-75 47%, P 



Author: Elmahashi, Mohamed O; Elbareg, Aisha M; Essadi, Fathi M; Ashur, Bashur M; Adam, Ishag

Source: https://archive.org/







Related documents